NASDAQ: IMTX
Immatics Nv Stock Forecast, Predictions & Price Target

Analyst price target for IMTX

Based on 1 analyst offering 12 month price targets for Immatics Nv

Min Forecast
$15.00+245.62%
Avg Forecast
$15.00+245.62%
Max Forecast
$15.00+245.62%

Should I buy or sell IMTX stock?

Based on 1 analyst offering ratings for Immatics Nv.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IMTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IMTX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their IMTX stock forecasts and price targets.

IMTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-19

1 of 1

Forecast return on equity

Is IMTX forecast to generate an efficient return?

Company
-15.37%
Industry
138.99%
Market
90.49%
IMTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMTX forecast to generate an efficient return on assets?

Company
-12.69%
Industry
36.84%
IMTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMTX earnings per share forecast

What is IMTX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.41-1,067.47%
Avg 2 year Forecast
-$1.41-1,065.75%
Avg 3 year Forecast
-$1.39-1,052.05%

IMTX revenue forecast

What is IMTX's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$59.5M-63.36%
Avg 2 year Forecast
$59.5M-63.36%
Avg 3 year Forecast
$114.3M-29.57%
IMTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMTX revenue growth forecast

How is IMTX forecast to perform vs Biotechnology companies and vs the US market?

Company
-16.49%
Industry
57.24%
Market
9.71%
IMTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMTX$4.34$15.00+245.62%Strong Buy
MRVI$2.06$5.29+156.89%Hold
TYRA$9.98$29.00+190.58%Strong Buy
VALN$6.38$15.33+140.33%Strong Buy
SVRA$2.97$7.67+158.15%Strong Buy

Immatics Nv Stock Forecast FAQ

Is Immatics Nv Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IMTX) stock is to Strong Buy IMTX stock.

Out of 1 analyst, 1 (100%) are recommending IMTX as a Strong Buy, 0 (0%) are recommending IMTX as a Buy, 0 (0%) are recommending IMTX as a Hold, 0 (0%) are recommending IMTX as a Sell, and 0 (0%) are recommending IMTX as a Strong Sell.

If you're new to stock investing, here's how to buy Immatics Nv stock.

What is IMTX's earnings growth forecast for 2025-2027?

(NASDAQ: IMTX) Immatics Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 25.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.88%.

Immatics Nv's earnings in 2025 is $16,541,304.On average, 4 Wall Street analysts forecast IMTX's earnings for 2025 to be -$171,689,614, with the lowest IMTX earnings forecast at -$195,695,772, and the highest IMTX earnings forecast at -$121,550,169. On average, 3 Wall Street analysts forecast IMTX's earnings for 2026 to be -$171,385,738, with the lowest IMTX earnings forecast at -$198,126,775, and the highest IMTX earnings forecast at -$121,550,169.

In 2027, IMTX is forecast to generate -$168,954,735 in earnings, with the lowest earnings forecast at -$168,954,735 and the highest earnings forecast at -$168,954,735.

What is IMTX's revenue growth forecast for 2025-2027?

(NASDAQ: IMTX) Immatics Nv's forecast annual revenue growth rate of -16.49% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 57.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.71%.

Immatics Nv's revenue in 2025 is $169,385,869.On average, 2 Wall Street analysts forecast IMTX's revenue for 2025 to be $7,229,804,052, with the lowest IMTX revenue forecast at $6,586,803,658, and the highest IMTX revenue forecast at $7,872,804,446. On average, 2 Wall Street analysts forecast IMTX's revenue for 2026 to be $7,229,804,052, with the lowest IMTX revenue forecast at $6,586,803,658, and the highest IMTX revenue forecast at $7,872,804,446.

In 2027, IMTX is forecast to generate $13,895,615,320 in revenue, with the lowest revenue forecast at $13,895,615,320 and the highest revenue forecast at $13,895,615,320.

What is IMTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: IMTX) forecast ROA is -12.69%, which is lower than the forecast US Biotechnology industry average of 36.84%.

What is IMTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IMTX price target, the average IMTX price target is $15.00, with the highest IMTX stock price forecast at $15.00 and the lowest IMTX stock price forecast at $15.00.

The Wall Street analyst predicted that Immatics Nv's share price could reach $15.00 by Nov 19, 2025. The average Immatics Nv stock price prediction forecasts a potential upside of 245.62% from the current IMTX share price of $4.34.

What is IMTX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IMTX) Immatics Nv's current Earnings Per Share (EPS) is $0.15. On average, analysts forecast that IMTX's EPS will be -$1.41 for 2025, with the lowest EPS forecast at -$1.61, and the highest EPS forecast at -$1.00. On average, analysts forecast that IMTX's EPS will be -$1.41 for 2026, with the lowest EPS forecast at -$1.63, and the highest EPS forecast at -$1.00. In 2027, IMTX's EPS is forecast to hit -$1.39 (min: -$1.39, max: -$1.39).

What is IMTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: IMTX) forecast ROE is -15.37%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.